These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4185513)

  • 1. ["Hypertensive vascular changes" with and without hypertension].
    Pasternack A
    Nord Med; 1969 Jul; 82(28):853-7. PubMed ID: 4185513
    [No Abstract]   [Full Text] [Related]  

  • 2. Vascular hypertrophy in hypertension: role of the renin-angiotensin system.
    Rosendorff C
    Mt Sinai J Med; 1998 Mar; 65(2):108-17. PubMed ID: 9520514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Primary and secondary aldosteronism in hypertension].
    Mertz DP
    Z Allgemeinmed; 1974 Apr; 50(12):566-71. PubMed ID: 4365194
    [No Abstract]   [Full Text] [Related]  

  • 4. [Determination of renin activity and aldosteronuria in 24 hypertensives].
    Sassard J; Bizollon A; Froment A; Vincent M; Lambrinidis S; Gharib C
    Rev Lyon Med; 1968 Oct; 17(16):697-706. PubMed ID: 4305353
    [No Abstract]   [Full Text] [Related]  

  • 5. [New data on hormone-dependent hypertension and their significance for the practice].
    Horký K; Petrásek J; Marek J
    Cas Lek Cesk; 1973 Jan; 112(1):3-11. PubMed ID: 4345613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Renin-angiotensin system in hypertension].
    Fyhrquist F
    Duodecim; 1974; 90(9):666-75. PubMed ID: 4371118
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased plasma renin substrate concentration in human malignant hypertension.
    Rosset E; Scherrer JR; Veyrat R
    Helv Med Acta; 1973 Oct; 37(4):235-50. PubMed ID: 4357903
    [No Abstract]   [Full Text] [Related]  

  • 8. Aldosteronism in hypertensive disease.
    Conn JW
    Med Times; 1970 Mar; 98(3):116-32. PubMed ID: 4313493
    [No Abstract]   [Full Text] [Related]  

  • 9. Vascular hypertrophy and hypertension: a role for growth factors?
    Lyall F; Lever AF; Morton JJ
    Acta Physiol Scand Suppl; 1988; 571():189-96. PubMed ID: 3239408
    [No Abstract]   [Full Text] [Related]  

  • 10. Does the rapidity with which hypertension reverses on unclipping a clipped kidney and on stopping long-term infusion of angiotensin II make unlikely an important role for vascular hypertrophy in maintaining the hypertension seen before reversal?
    Folkow B; Lever AF
    J Hum Hypertens; 1995 Jun; 9(6):487-8. PubMed ID: 7473532
    [No Abstract]   [Full Text] [Related]  

  • 11. Inflammatory cellular reaction in hypertensive vascular disease in man.
    Olsen F
    Acta Pathol Microbiol Scand A; 1972; 80(2):253-6. PubMed ID: 5028054
    [No Abstract]   [Full Text] [Related]  

  • 12. Vascular lesions and angiotensin in malignant hypertension in the absence of vasopressin.
    Woods RL; Abrahams JM; Kincaid-Smith P; Johnston CI
    Clin Exp Pharmacol Physiol; 1982; 9(3):297-301. PubMed ID: 6754178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic clamping of renin gene expression induces hypertension and elevation of intrarenal Ang II levels of graded severity in Cyp1a1-Ren2 transgenic rats.
    Mitchell KD; Bagatell SJ; Miller CS; Mouton CR; Seth DM; Mullins JJ
    J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7(2):74-86. PubMed ID: 17083061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Importance of renin-angiotensin-aldosterone system in diverse forms of hypertension].
    Werning C; Weidmann P; Vetter W; Stiel D; Schweikert HU; Siegenthaler W
    Schweiz Rundsch Med Prax; 1970 May; 59(20):730-7. PubMed ID: 4321141
    [No Abstract]   [Full Text] [Related]  

  • 15. Vascular synthesis of aldosterone: role in hypertension.
    Takeda Y
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):75-9. PubMed ID: 15134804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The production and resolution of hypertensive vascular lesions in the rabbit.
    Allison PR; Bleehan N; Brown W; Pickering GW; Robb-Smith AH; Russell RP
    Clin Sci; 1967 Aug; 33(1):39-51. PubMed ID: 6059303
    [No Abstract]   [Full Text] [Related]  

  • 17. A study of the inhibition of the renin-angiotensin system in renal potassium wasting syndromes, including Bartter's syndrome.
    Godard C; Vallotton MB; Broyer M; Royer P
    Helv Paediatr Acta; 1972 Nov; 27(5):495-511. PubMed ID: 4344982
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experimental hypertension].
    Tria E; Rulli V
    Recenti Prog Med; 1966 Oct; 41(4):297-319. PubMed ID: 4296421
    [No Abstract]   [Full Text] [Related]  

  • 19. Malignant hypertension in Brattleboro (vasopressin-deficient) rats.
    Woods RL; Abrahams JM; Kincaid-Smith P; Johnston CI
    J Hypertens; 1983 Jun; 1(1):37-43. PubMed ID: 6397512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The renin-angiotensin-aldosterone system in arterial hypertension].
    Bar-Andziak E; Feltynowski T
    Kardiol Pol; 1971; 14(3):309-16. PubMed ID: 4330165
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.